Imaging of the Failing Heart

Cohn JN Johnson GR Shabeti R : Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993;87: VI–16.

Fallavollita JA Jacob S Young RF : Regional alterations in SR Ca(2+)-ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium. Am J Physiol 1999;277:H1418–28.

Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology: Remme WJ, Swedberg K (Co-chairmen). Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527–1560.

Mock MB Ringqvist I Fisher LD : Survival of medically treated patients in the Coronary Artery Surgery Study (CASS). Circulation 1982;66:562–568.

Bax JJ Poldermans D Elhendy A : Sensitivity, specificity and predictive accuracies of various non-invasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:141–188.

Schinkel AF Bax JJ Sozzi FB Boersma E Valkema R Elhendy A Roelandt JR Poldermans D : Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction. Heart. 2002;88(2):125–130.

von Dahl J Altehoefer C Sheehan FH : Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. J Am Coll Cardiol 1996;28:948–958.

Vanoverschelde JL Depre C Gerber BL : Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol 2000;85:1432–1439.

Auerbach MA Schroder H Hoh C : Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation 1999;99:2921–2926.

Haas F Haehnel CJ Picker W : Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 1997;30:1693–1700.

Beanlands RS DeKemp RA Smith S : F-18 fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function. Am J Cardiol 1997;79:1092–1095.

Underwood SR Bax JJ von Dahl J Henein MY Knuuti J van Rossum AC Schwarz ER Vanoverschelde JL van der Wall EE Wijns W ; Study Group of the European Society of Cardiology: Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J. 2004;25(10):81–836.

Tillisch J Brunken R Marshall R : Reversibility of cardiac wallmotion abnormalities predicted by positron emission tomography. N Engl J Med 1986;314:884–888.

Knuuti MJ Saraste M Nuutila P Harkonen R Wegelius U Haapanen A Bergman J Haaparanta M Savunen T Voipio-Pulkki LM : Myocardial viability: Fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. Am Heart J. 1994 Apr; 127(4 Pt 1:785–796.

Vanoverschelde J-LJ DeHondt A-M Marwick T : Head-to-head comparison of exercise-redistribution-reinjection thallium single photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996;28:432–442.

Gunning MG Anagnostopoulos C Knight CJ : Comparison of Tl-201, technetium-99m tetrofosmin and dobutamine magnetic resonance imaging in identifying hibernating myocardium. Circulation 1998;98:1869–1874.

Udelson JE Coleman PS Metherall J : Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 1994;89:2552–2561.

Sciagra R Bisi G Santoro GM : Influence of the assessment of defect severity and intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardium with data-based quantitative technetium 99m-labelled sestamibi single photon emission computed tomography. J Nucl Cardiol 1996;3:221–230.

Burt RW Perkins OW Oppenheim BE : Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability. J Nucl Med 1995;36:176–179.

Previtali M Poli A Lanzarini L : Dobutamine stress echocardiography for assessment of myocardial viability and ischaemia in acute myocardial infarction treated with thrombolysis. Am J Cardiol 1993;72:124G–30G.

Lauerma K Niemi P Hanninen H Janatuinen T Voipio-Pulkki LM Knuuti J Toivonen L Makela T Makijarvi MA Aronen HJ : Multimodality MR imaging assessment of myocardial viability: Combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience. Radiology 2000;217(3):729–736.

Baer FM Theissen P Crnac J : Head to head comparison of dobutamine-transoesophageal echocardiography and dobutaminemagnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J 2000;21:981–991.

Higgins CB : Prediction of myocardial viability by MRI. Circulation 1999;99:727–729.

Geskin G Kramer CM Rogers WJ : Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. Circulation 1998;98:217–223.

Nagel E Lehmkuhl HB Bocksch W : Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of highdose dobutamine stress MRI: Comparison with dobutamine stress echocardiography. Circulation 1999;99:763–770.

Hundley WG Hamilton CA Thomas MS : Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 1999;100:1697–702.

Wagner A Mahrholdt H Regenfus M : Contrast-enhanced MIR and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study. Lancet 2003;361:374–379.

Forder JR Pohost GM : Cardiovascular nuclear magnetic resonance: Basic and clinical applications. J Clin Invest 2003;111:1630–1639.

Mahnken AH Koos R Katoh M : Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol 2005;45:2042–2047.

Kitsiou AN Srinivasan G Quyyumi AA Summers RM Bacharach SL Dilsizian V : Stress-induced reversible and mild-to-moderate irreversible thallium defects: Are they equally accurate for predicting recovery of regional left ventricular function after revascularization? Circulation 1998;98(6):501–508.

Isbell DC Kramer CM : Magnetic resonance for the assessment of myocardial viability. Curr Opin Cardiol 2006;21(5):469–472.

Kim RJ Wu E Rafael A Chen EL Parker MA Simonetti O Klocke FJ Bonow RO Judd RM : The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343(20):1445–1453.

Kaandorp TA Lamb HJ van der Wall EE De Roos A Bax JJ : Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction. Heart 2005;91(10):1359–1365.

Bax JJ Poldermans D Elhendy A : Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999;34:163–169.

Eitzman D Al-Aouar ZR Kanter HL : Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559–565.

Di Carli M Davidson M Little R : Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527–353.

Di Carli MF Asgarzadie F Schelbert HR Brunken RC Laks H Phelps ME Maddahi J : Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92(12):3436–344.

Allman KC Shaw LJ Hachamovitch R Udelson JE : Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol 2002;39(7):1151–1158.